$77.44▾ 1.86%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$-197.54MTTM operating cash
Pre-profit
It is still burning cash while pre-profit.
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Lowdebt to assets
Strong
Very low debt relative to its asset base.
More coming: dilution / share-count creep.
✦ The read
Disc Medicine, Inc. is pre-profit. It is still burning cash while pre-profit. Very low debt relative to its asset base.
Key numbers
Valuation
EPS (TTM)$-6.58
TTM (trailing 12 months, through fiscal Q2 FY2026)
Size
Revenue (TTM)$0.00
TTM (trailing 12 months, through fiscal Q2 FY2026)
Recent news
Sentiment · last 30 days6 articles
0 bullish0 neutral6 bearish
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Verra Mobility Corporation Investors with Losses to Secure Counsel Before Important August 4 Deadline in Securities Class Action - VRRM
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Putnam Investor News: If You Have Suffered Losses in Putnam Investment Management LLC, You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Signals and key numbers are from the fiscal Q2 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.